NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that United Healthcare, one of the largest healthcare providers in the United States, has approved reimbursement for the company’s breakthrough Portable Neuromodulation Stimulator (PoNS) Device. This marks the second major healthcare provider to grant reimbursement coverage for the device, a significant step in improving access for patients with multiple sclerosis (MS).
The approved reimbursement amount totals $18,100, inclusive of patient co-payments. This figure reflects the typical adjusted price for out-of-network claims and represents an important validation of both the clinical need and the overall value of the PoNS Device.
A Breakthrough for Patients and Payor Relationships
The PoNS Device is a non-invasive solution designed to improve walking in patients with gait deficit resulting from MS. This condition impacts mobility and quality of life, making advancements in treatment critical for patients’ day-to-day functioning. The reimbursement decision is emblematic of the increasing acceptance of the device’s therapeutic benefits.
“This additional claim approval and reimbursement from a second major healthcare provider at typical out-of-network adjusted price further validates the clinical need and benefits of PoNS and reinforces the true value of the device,” said Dane Andreeff, Helius President and Chief Executive Officer.
Helius has been laser-focused on advancing conversations with payors to address the needs of MS patients. “We believe this pricing should support further constructive conversations with payors,” Andreeff added. “We continue to pursue commercial payor coverage and broad third-party reimbursement as part of our growth strategy to increase patient access to PoNS. We are pleased with this progress in our efforts to support more MS patients.”
Broader Implications for Healthcare Coverage
The approval by a second major healthcare provider marks a critical milestone for Helius Medical Technologies, as the company continues expanding its market presence and patient outreach. Having reimbursement supported at typical out-of-network levels demonstrates how the device aligns with coverage frameworks, laying the groundwork for future partnerships with additional insurers.
For patients, the approval represents a path to reduced financial barriers, enabling greater access to cutting-edge treatments. Healthcare providers and insurers, meanwhile, are positioned to increasingly recognize the role PoNS can play in improving mobility and health outcomes for MS patients.
Looking Ahead
With this development, Helius Medical Technologies takes a significant step forward in its mission to make the PoNS Device a widely accessible therapeutic option. The reimbursement by United Healthcare paves the way for further discussions with major insurers, potentially accelerating adoption and coverage nationwide.
This announcement spotlights the company’s efforts to enhance patient care and reflects growing confidence in the PoNS Device as a game-changing technology for those living with MS. As Helius pursues broader payor inclusion and greater financial accessibility, the potential for expanding patient access and improving quality of life remains promising.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.